SEC Form 4 · accession 0001628280-26-058107
Camp4 Therapeutics Corp · CAMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Tardiff
Officer — Chief Scientific Officer
Period of report
Aug 19, 2026
Accepted (ET)
Aug 19, 2026 · 8:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001736730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2026 | S | 1,738 | $4.76 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares sold were previously acquired by the reporting person pursuant to the CAMP4 Therapeutics Corporation Employee Stock Purchase Plan (the "ESPP") for the purchase period of January 1, 2026 through June 30, 2026 in a transaction that was exempt under Rule 16b-3(c).